Heart checkup 5 years after MIS-C
Part of Infections, Lungs & breathing clinical trials.
This study looks at the heart health of children and teens who had MIS-C (a rare inflammatory condition linked to COVID-19) about 5 years later. It will compare their results to those of healthy children, to see if there are any lasting effects on the heart.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child had MIS-C (diagnosed by WHO criteria).
- A parent or guardian must sign a permission form.
- If you are 16 or older, you may also need to sign a form agreeing to take part.
- You cannot have known heart disease (including from birth) or any serious chronic health condition that affects growth, daily life, or development.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how children feel and live their daily lives after recovering from MIS-C (a severe inflammatory condition linked to COVID-19). It compares them to healthy children of the same age and gender to see if there are any lasting effects.
This study looks at what long-term health effects children may have after getting COVID-19, and how those effects change over time. You may be asked to share health information and possibly complete a scan that can’t be done if certain metal is present.
This trial is studying children who are very sick from COVID-19 or have a related condition called MIS-C. It aims to understand how severe COVID-19 affects children and improve care.
This study looks at heart disease risk in children and young adults (ages 6-25) with long-term health conditions like certain heart, kidney, or diabetes disorders. The goal is to better understand and manage heart risks early.
This study looks at how fitness, sleep, and diet during childhood affect heart and metabolic health in teenagers and young adults. It uses data and samples already collected from participants in earlier studies.
This trial looks at how persistent heart-related changes after a past COVID infection may be affected by study treatments. It mainly seeks people who are stable enough for follow-up visits and heart imaging, and who are not already on the specific heart medications required.
Hear when a new Multisystem Inflammatory Syndrome in Children (MIS-C) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.